Bel   ·  Eng   ·  Rus  |    Text only  |   NASB in Facebook NASB in Vkontakte NASB in Twitter NASB in Instagram NASB in Youtube NASB in LinkedIn NASB in SlideShare rss Mail 
   
The Official Internet Portal of the President of the Republic of Belarus
The Official Internet Site of the Council of Ministers of the Republic of Belarus
List of Administrative Procedures Carried out by NAS of Belarus and its Organizations
The national legal Internet portal of the Republic of Belarus
The Academy of Public Administration under the aegis of the President of the Republic of Belarus
Internet portal Youth of Belarus
Republican Center for Technology Transfer
Республиканский Центр Трансфера Технологий
Belt and Road Forum for Regional Cooperation and Development

NASB scientists take part in press conference on scientific support of pharmaceutical industry

Homepage / News / News Archive / 2019 
 

18.12.2018 On 18 December 2018, a press conference on scientific support of the pharmaceutical industry and new achievements of the Academy’s scientists was held at the Press Center of the Press House. The event was attended by Elena Kalinichenko, Deputy Director for Research and Innovation of the NASB Institute of Bioorganic Chemistry, Head of the ChemPharmSynthesis Research and Production Center, Corresponding Member of the NAS of Belarus; Zoya Kuvaeva, Head of the Department of Medicinal Substances of the NASB Institute of Physical and Organic Chemistry, Doctor of Chemistry, Professor, Scientific Director of the Amino Acids Center; and Olga Kazyuchits, Deputy Director for Research of the Akadempharm Republican Manufacturing Unitary Enterprise.

Elena Kalinichenko told the journalists that the NASB Institute of Bioorganic Chemistry registered the first original drug Leykovir for treatment of patients suffering from multiple sclerosis. She explained that the disease, when progressing, led to complete disability of a person, and the drug could stop the process of destruction of certain areas, inflamed in the brain.

Olga Kazyuchits reported that the Akadempharm completed the year worthily. In 2018, the company will let out products worth Br21 million.

Zoya Kuvaeva informed the media about the work of the NASB Institute of Physical and Organic Chemistry on the development of new drugs based on the compositions of amino acids and their derivatives.

The participants of the press event answered the journalists' questions.



Возврат к списку

Homepage / News / News Archive / Back to Top of Page